Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immune Tolerance | 12 | 2017 | 2300 | 1.480 |
Why?
|
Histocompatibility, Maternal-Fetal | 3 | 2018 | 9 | 1.180 |
Why?
|
Histocompatibility Testing | 9 | 2024 | 719 | 1.110 |
Why?
|
Isoantibodies | 6 | 2023 | 674 | 1.030 |
Why?
|
Maternal-Fetal Exchange | 4 | 2018 | 463 | 0.950 |
Why?
|
Graft Rejection | 16 | 2024 | 4446 | 0.760 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2021 | 3075 | 0.730 |
Why?
|
Placentation | 1 | 2021 | 78 | 0.730 |
Why?
|
HLA Antigens | 8 | 2024 | 1371 | 0.710 |
Why?
|
Receptors, Virus | 2 | 2015 | 640 | 0.710 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2024 | 1355 | 0.690 |
Why?
|
Transplants | 1 | 2019 | 207 | 0.550 |
Why?
|
Th17 Cells | 2 | 2015 | 793 | 0.550 |
Why?
|
Reproduction | 1 | 2021 | 645 | 0.540 |
Why?
|
Kidney Transplantation | 7 | 2024 | 4236 | 0.530 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2016 | 82 | 0.530 |
Why?
|
Transplantation Tolerance | 2 | 2018 | 605 | 0.500 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2014 | 3441 | 0.480 |
Why?
|
Membrane Glycoproteins | 6 | 2007 | 3701 | 0.480 |
Why?
|
Lung Transplantation | 6 | 2024 | 1309 | 0.480 |
Why?
|
Immunity, Maternally-Acquired | 2 | 2021 | 111 | 0.460 |
Why?
|
Uterus | 2 | 2015 | 649 | 0.450 |
Why?
|
Placenta | 5 | 2015 | 1708 | 0.450 |
Why?
|
Stem Cell Transplantation | 2 | 2019 | 1598 | 0.430 |
Why?
|
Peptides | 6 | 2007 | 4342 | 0.420 |
Why?
|
Mice, Inbred CBA | 5 | 2015 | 436 | 0.410 |
Why?
|
Amino Sugars | 1 | 2011 | 39 | 0.400 |
Why?
|
Listeriosis | 3 | 2006 | 150 | 0.390 |
Why?
|
Fetus | 3 | 2015 | 1864 | 0.370 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 2001 | 186 | 0.350 |
Why?
|
Heart Transplantation | 8 | 2018 | 3234 | 0.330 |
Why?
|
Dendritic Cells | 8 | 2018 | 2746 | 0.320 |
Why?
|
Organ Transplantation | 1 | 2019 | 1157 | 0.310 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2020 | 4371 | 0.310 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2011 | 822 | 0.310 |
Why?
|
Immunity, Cellular | 2 | 2017 | 1560 | 0.300 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2011 | 1445 | 0.300 |
Why?
|
Mice, Inbred NOD | 8 | 2020 | 1825 | 0.290 |
Why?
|
Th1 Cells | 5 | 2011 | 1037 | 0.280 |
Why?
|
Antibodies | 4 | 2017 | 2421 | 0.280 |
Why?
|
Tissue Donors | 9 | 2023 | 2331 | 0.280 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2947 | 0.280 |
Why?
|
Interleukin-17 | 2 | 2020 | 911 | 0.280 |
Why?
|
Pregnancy | 11 | 2021 | 29858 | 0.270 |
Why?
|
Immunologic Factors | 3 | 2014 | 1589 | 0.260 |
Why?
|
Mice, Inbred C57BL | 19 | 2018 | 22154 | 0.260 |
Why?
|
Mice | 34 | 2024 | 81474 | 0.260 |
Why?
|
Fetal Resorption | 1 | 2005 | 15 | 0.260 |
Why?
|
CD8-Positive T-Lymphocytes | 8 | 2024 | 4576 | 0.260 |
Why?
|
Polysaccharides | 1 | 2011 | 1014 | 0.240 |
Why?
|
Adoptive Transfer | 3 | 2014 | 819 | 0.240 |
Why?
|
Antibodies, Monoclonal | 7 | 2017 | 9180 | 0.230 |
Why?
|
Interleukin-6 | 4 | 2018 | 3210 | 0.220 |
Why?
|
Physicians | 1 | 2022 | 4591 | 0.220 |
Why?
|
Immunity, Innate | 2 | 2012 | 3060 | 0.220 |
Why?
|
Myocarditis | 1 | 2011 | 786 | 0.220 |
Why?
|
Hypersensitivity, Delayed | 1 | 2024 | 490 | 0.220 |
Why?
|
Animals | 37 | 2024 | 168388 | 0.210 |
Why?
|
Transplantation Immunology | 2 | 2017 | 532 | 0.210 |
Why?
|
Mice, Knockout | 13 | 2018 | 14409 | 0.200 |
Why?
|
Reperfusion Injury | 2 | 2018 | 1023 | 0.180 |
Why?
|
T-Lymphocytes | 7 | 2020 | 10191 | 0.180 |
Why?
|
Mice, Mutant Strains | 2 | 2001 | 1751 | 0.180 |
Why?
|
Autoimmunity | 2 | 2007 | 1355 | 0.170 |
Why?
|
Pregnancy, Animal | 1 | 2000 | 124 | 0.170 |
Why?
|
Viral Matrix Proteins | 1 | 2020 | 196 | 0.170 |
Why?
|
Antigens | 2 | 2023 | 1446 | 0.170 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 61 | 0.160 |
Why?
|
Signal Transduction | 8 | 2018 | 23427 | 0.160 |
Why?
|
Graft vs Host Disease | 2 | 2023 | 3030 | 0.160 |
Why?
|
Isoantigens | 3 | 2017 | 552 | 0.160 |
Why?
|
Antigens, Surface | 3 | 2008 | 1609 | 0.160 |
Why?
|
Alleles | 2 | 2023 | 6909 | 0.160 |
Why?
|
Skin | 2 | 2024 | 4482 | 0.160 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2018 | 85 | 0.160 |
Why?
|
Trophoblasts | 1 | 2000 | 224 | 0.150 |
Why?
|
Graft Survival | 8 | 2018 | 3818 | 0.150 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2008 | 1135 | 0.150 |
Why?
|
Killer Cells, Natural | 2 | 2018 | 2203 | 0.150 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2024 | 1783 | 0.150 |
Why?
|
Immunomodulation | 1 | 2021 | 547 | 0.140 |
Why?
|
Immunomagnetic Separation | 1 | 2016 | 79 | 0.140 |
Why?
|
Models, Immunological | 1 | 2018 | 512 | 0.130 |
Why?
|
Histocompatibility | 1 | 2017 | 317 | 0.130 |
Why?
|
Medical Tourism | 1 | 2016 | 52 | 0.130 |
Why?
|
Autoantibodies | 1 | 2024 | 2123 | 0.130 |
Why?
|
Female | 31 | 2024 | 392485 | 0.130 |
Why?
|
Bronchiolitis Obliterans | 1 | 2017 | 213 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 825 | 0.130 |
Why?
|
Lymph Nodes | 3 | 2018 | 3469 | 0.120 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2016 | 303 | 0.120 |
Why?
|
Mice, Inbred BALB C | 9 | 2018 | 6210 | 0.120 |
Why?
|
Chemokines | 2 | 2015 | 960 | 0.120 |
Why?
|
Herpesvirus 4, Human | 1 | 2020 | 1079 | 0.120 |
Why?
|
Pregnancy Outcome | 2 | 2021 | 2920 | 0.120 |
Why?
|
Th2 Cells | 4 | 2011 | 1058 | 0.120 |
Why?
|
Macrophages | 2 | 2018 | 5768 | 0.120 |
Why?
|
Cells, Cultured | 9 | 2020 | 18962 | 0.120 |
Why?
|
Cross Reactions | 1 | 2016 | 818 | 0.120 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2018 | 480 | 0.120 |
Why?
|
Interleukin-15 | 1 | 2015 | 185 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2020 | 1994 | 0.110 |
Why?
|
Interferon-gamma | 5 | 2020 | 3159 | 0.110 |
Why?
|
Antigens, Ly | 1 | 2015 | 294 | 0.110 |
Why?
|
Drug Carriers | 1 | 2018 | 706 | 0.110 |
Why?
|
Kidney | 3 | 2023 | 7049 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5670 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2549 | 0.110 |
Why?
|
Litter Size | 1 | 2013 | 49 | 0.110 |
Why?
|
Embryo Loss | 1 | 2013 | 55 | 0.110 |
Why?
|
B-Lymphocytes | 3 | 2020 | 4764 | 0.110 |
Why?
|
Vaccines, Synthetic | 1 | 1996 | 619 | 0.110 |
Why?
|
Spleen | 3 | 2018 | 2296 | 0.110 |
Why?
|
BCG Vaccine | 1 | 1996 | 369 | 0.110 |
Why?
|
Mice, Transgenic | 5 | 2018 | 9534 | 0.110 |
Why?
|
Flow Cytometry | 4 | 2013 | 5866 | 0.100 |
Why?
|
Vaccines, Inactivated | 1 | 1993 | 179 | 0.100 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 117 | 0.100 |
Why?
|
Glomerulonephritis | 1 | 2014 | 336 | 0.100 |
Why?
|
Kidney Glomerulus | 1 | 2014 | 567 | 0.100 |
Why?
|
Lectins, C-Type | 1 | 2015 | 584 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1092 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 892 | 0.100 |
Why?
|
Neutrophils | 2 | 2001 | 3765 | 0.090 |
Why?
|
Antibody Specificity | 1 | 2013 | 1060 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2048 | 0.090 |
Why?
|
Immunotherapy | 2 | 2019 | 4649 | 0.090 |
Why?
|
Trachea | 1 | 2017 | 1089 | 0.090 |
Why?
|
Humans | 33 | 2024 | 761326 | 0.090 |
Why?
|
Cell Movement | 3 | 2018 | 5202 | 0.090 |
Why?
|
Biological Assay | 1 | 2013 | 626 | 0.090 |
Why?
|
Microspheres | 1 | 2013 | 785 | 0.090 |
Why?
|
Cytokines | 6 | 2018 | 7390 | 0.090 |
Why?
|
Immunophenotyping | 1 | 2015 | 1870 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 941 | 0.090 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 421 | 0.090 |
Why?
|
Surgical Sponges | 1 | 2009 | 39 | 0.090 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2008 | 306 | 0.080 |
Why?
|
Transplantation, Homologous | 6 | 2018 | 4810 | 0.080 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1996 | 832 | 0.080 |
Why?
|
Lymphocyte Activation | 5 | 2019 | 5491 | 0.080 |
Why?
|
Nanoparticles | 2 | 2018 | 1955 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1600 | 0.080 |
Why?
|
Coculture Techniques | 1 | 2012 | 1341 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 910 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2014 | 997 | 0.080 |
Why?
|
Spinal Cord | 1 | 2016 | 1817 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2605 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1909 | 0.070 |
Why?
|
Male | 21 | 2024 | 360621 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2019 | 5114 | 0.070 |
Why?
|
Vascular Patency | 1 | 2009 | 910 | 0.070 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2009 | 292 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2009 | 537 | 0.070 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18234 | 0.070 |
Why?
|
Mycobacterium tuberculosis | 2 | 1996 | 1913 | 0.060 |
Why?
|
Mice, SCID | 3 | 2020 | 2625 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1926 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2820 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2223 | 0.060 |
Why?
|
Lymphocyte Depletion | 1 | 2007 | 602 | 0.060 |
Why?
|
Cell Separation | 1 | 2011 | 1722 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2007 | 899 | 0.060 |
Why?
|
Lymphocytes | 1 | 2013 | 2610 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1805 | 0.060 |
Why?
|
Fathers | 1 | 2007 | 376 | 0.060 |
Why?
|
Upper Extremity | 1 | 2009 | 657 | 0.060 |
Why?
|
Endothelial Cells | 2 | 2024 | 3543 | 0.060 |
Why?
|
Forkhead Transcription Factors | 2 | 2008 | 1612 | 0.060 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.060 |
Why?
|
Melanoma | 2 | 2019 | 5706 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5970 | 0.050 |
Why?
|
Tissue Scaffolds | 1 | 2009 | 936 | 0.050 |
Why?
|
Homeodomain Proteins | 2 | 2018 | 2413 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2011 | 2133 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 11900 | 0.050 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2007 | 740 | 0.050 |
Why?
|
Prediabetic State | 1 | 2008 | 549 | 0.050 |
Why?
|
Heart Diseases | 1 | 2015 | 2785 | 0.050 |
Why?
|
Treatment Outcome | 7 | 2019 | 64645 | 0.050 |
Why?
|
Blood Group Incompatibility | 1 | 2023 | 136 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4432 | 0.050 |
Why?
|
Abortion, Spontaneous | 1 | 2007 | 533 | 0.050 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2024 | 243 | 0.050 |
Why?
|
Neoplasms | 3 | 2020 | 22158 | 0.050 |
Why?
|
Microscopy, Electron | 2 | 2015 | 2560 | 0.050 |
Why?
|
Drug Eruptions | 1 | 2024 | 335 | 0.050 |
Why?
|
Islets of Langerhans | 1 | 2007 | 1346 | 0.050 |
Why?
|
OX40 Ligand | 1 | 2020 | 55 | 0.050 |
Why?
|
Tuberculosis | 1 | 1993 | 2016 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2020 | 4280 | 0.040 |
Why?
|
ABO Blood-Group System | 1 | 2023 | 380 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2009 | 1801 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5820 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1427 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1661 | 0.040 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2019 | 123 | 0.040 |
Why?
|
Lymphotoxin beta Receptor | 1 | 2018 | 25 | 0.040 |
Why?
|
Lymphotoxin-alpha | 1 | 2018 | 95 | 0.040 |
Why?
|
Cell Line | 1 | 2012 | 15599 | 0.040 |
Why?
|
Adult | 12 | 2024 | 221122 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7852 | 0.040 |
Why?
|
Living Donors | 1 | 2023 | 641 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2000 | 664 | 0.040 |
Why?
|
Abscess | 1 | 2001 | 606 | 0.040 |
Why?
|
Middle Aged | 11 | 2024 | 220774 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 17872 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2018 | 739 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 964 | 0.030 |
Why?
|
Apoptosis | 1 | 2012 | 9474 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13635 | 0.030 |
Why?
|
Homozygote | 1 | 2001 | 1796 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3572 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6392 | 0.030 |
Why?
|
Paraplegia | 1 | 2016 | 162 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2023 | 2693 | 0.030 |
Why?
|
Mycobacterium bovis | 1 | 1996 | 147 | 0.030 |
Why?
|
Aged | 9 | 2024 | 169179 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 859 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2019 | 605 | 0.030 |
Why?
|
Leprostatic Agents | 1 | 1994 | 14 | 0.030 |
Why?
|
Leprosy, Lepromatous | 1 | 1994 | 23 | 0.030 |
Why?
|
Nephritis | 1 | 2015 | 146 | 0.030 |
Why?
|
Heterozygote | 1 | 2001 | 2803 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2015 | 302 | 0.030 |
Why?
|
Phenotype | 1 | 2011 | 16603 | 0.030 |
Why?
|
Up-Regulation | 2 | 2017 | 4120 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 1996 | 656 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 16966 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2018 | 4175 | 0.030 |
Why?
|
Biopsy | 2 | 2015 | 6768 | 0.030 |
Why?
|
Prospective Studies | 4 | 2020 | 54405 | 0.030 |
Why?
|
Insulin | 1 | 2006 | 6595 | 0.020 |
Why?
|
Bacterial Vaccines | 1 | 1994 | 401 | 0.020 |
Why?
|
Safety | 1 | 1996 | 1150 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1050 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2018 | 4173 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 835 | 0.020 |
Why?
|
Immunocompetence | 1 | 2010 | 138 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1229 | 0.020 |
Why?
|
Receptors, Interleukin-8A | 1 | 2009 | 46 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2010 | 621 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2019 | 10431 | 0.020 |
Why?
|
Genes, MHC Class II | 1 | 2009 | 451 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 12982 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4567 | 0.020 |
Why?
|
Ligands | 1 | 2015 | 3271 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1943 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5034 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9319 | 0.020 |
Why?
|
Cohort Studies | 3 | 2017 | 41440 | 0.020 |
Why?
|
Immunity | 1 | 1993 | 997 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1640 | 0.020 |
Why?
|
CD40 Ligand | 1 | 2009 | 526 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10764 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80575 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20092 | 0.020 |
Why?
|
Liver | 1 | 2001 | 7531 | 0.020 |
Why?
|
Preoperative Care | 1 | 2014 | 2242 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2017 | 3666 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10075 | 0.020 |
Why?
|
Monocytes | 1 | 2014 | 2573 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 2006 | 279 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11098 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2014 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3489 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8632 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 2006 | 250 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5310 | 0.010 |
Why?
|
Disease Progression | 2 | 2014 | 13500 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2062 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2010 | 1891 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2016 | 3048 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 23981 | 0.010 |
Why?
|
Time Factors | 2 | 2017 | 39974 | 0.010 |
Why?
|
Epitopes | 1 | 2008 | 2504 | 0.010 |
Why?
|
Pancreas | 1 | 2008 | 1689 | 0.010 |
Why?
|
Organ Specificity | 1 | 2006 | 1967 | 0.010 |
Why?
|
Remission Induction | 1 | 2006 | 2395 | 0.010 |
Why?
|
Kinetics | 1 | 2008 | 6374 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 1959 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11070 | 0.010 |
Why?
|
Sirolimus | 1 | 2007 | 1533 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12787 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9414 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7999 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1791 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6473 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6525 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5247 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15262 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22124 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10760 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12059 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12450 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29588 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12329 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18401 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3396 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8470 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39108 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2008 | 11531 | 0.010 |
Why?
|
Child | 2 | 1996 | 80156 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74152 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 59196 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36430 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1994 | 6309 | 0.000 |
Why?
|
Adolescent | 1 | 2010 | 88305 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1994 | 8526 | 0.000 |
Why?
|
United States | 1 | 2009 | 72317 | 0.000 |
Why?
|